Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOSTRIL: Doxycycline for HHT Epistaxis
NCT04167085Phase 4Completed
- Sponsor
- University of California, Los Angeles
- Start
- Dec 2017
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of doxycycline in hereditary hemorrhagic telangiectasia (HHT), sponsored by University of California, Los Angeles. Started Dec 2017; status: completed.
02
Drugs
doxycycline
03
Conditions
hereditary hemorrhagic telangiectasia (HHT)
Beyond the preview
Go deeper on NCT04167085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04167085.